Priscilla H Yong1, Laurence Weinberg2, Niloufar Torkamani1,3, Leonid Churilov4, Raymond J Robbins5, Ronald Ma6, Rinaldo Bellomo7,8,9, Que T Lam10, James D Burns11, Graeme K Hart7, Jeremy F Lew1, Johan Mårtensson7,12, David Story2,8, Andrew N Motley13, Douglas Johnson1,14, Jeffrey D Zajac1,3, Elif I Ekinci15,3. 1. Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia. 2. Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia. 3. Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia. 4. The Florey Institute of Neuroscience & Mental Health, Melbourne, Victoria, Australia. 5. Department of Administrative Informatics, Austin Health, Heidelberg, Victoria, Australia. 6. Clinical Costing Finance, Austin Health, Heidelberg, Victoria, Australia. 7. Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia. 8. Centre for Integrated Critical Care, The University of Melbourne, Parkville, Victoria, Australia. 9. Australian and New Zealand Intensive Care Society Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. 10. Department of Pathology, Austin Health, Heidelberg, Victoria, Australia. 11. Clinical Informatics Unit, Austin Health, Heidelberg, Victoria, Australia. 12. Section of Anesthesia and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. 13. Quality and Patient Safety Unit, Austin Health, Heidelberg, Victoria, Australia. 14. Department of General Medicine, Austin Health, Heidelberg, Victoria, Australia. 15. Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia elif.ekinci@unimelb.edu.au.
Abstract
OBJECTIVE: Limited studies have examined the association between diabetes and HbA1c with postoperative outcomes. We investigated the association of diabetes, defined categorically, and the association of HbA1c as a continuous measure, with postoperative outcomes. RESEARCH DESIGN AND METHODS: In this prospective, observational study, we measured the HbA1c of surgical inpatients age ≥54 years at a tertiary hospital between May 2013 and January 2016. Patients were diagnosed with diabetes if they had preexisting diabetes or an HbA1c ≥6.5% (48 mmol/mol) or with prediabetes if they had an HbA1c between 5.7 and 6.4% (39 and 48 mmol/mol). Patients with an HbA1c <5.7% (39 mmol/mol) were categorized as having normoglycemia. Baseline demographic and clinical data were obtained from hospital records, and patients were followed for 6 months. Random-effects logistic and negative binomial regression models were used for analysis, treating surgical units as random effects. We undertook classification and regression tree (CART) analysis to design a 6-month mortality risk model. RESULTS: Of 7,565 inpatients, 30% had diabetes, and 37% had prediabetes. After adjusting for age, Charlson comorbidity index (excluding diabetes and age), estimated glomerular filtration rate, and length of surgery, diabetes was associated with increased 6-month mortality (adjusted odds ratio [aOR] 1.29 [95% CI 1.05-1.58]; P = 0.014), major complications (1.32 [1.14-1.52]; P < 0.001), intensive care unit (ICU) admission (1.50 [1.28-1.75]; P < 0.001), mechanical ventilation (1.67 [1.32-2.10]; P < 0.001), and hospital length of stay (LOS) (adjusted incidence rate ratio [aIRR] 1.08 [95% CI 1.04-1.12]; P < 0.001). Each percentage increase in HbA1c was associated with increased major complications (aOR 1.07 [1.01-1.14]; P = 0.030), ICU admission (aOR 1.14 [1.07-1.21]; P < 0.001), and hospital LOS (aIRR 1.05 [1.03-1.06]; P < 0.001). CART analysis confirmed a higher risk of 6-month mortality with diabetes in conjunction with other risk factors. CONCLUSIONS: Almost one-third of surgical inpatients age ≥54 years had diabetes. Diabetes and higher HbA1c were independently associated with a higher risk of adverse outcomes after surgery.
OBJECTIVE: Limited studies have examined the association between diabetes and HbA1c with postoperative outcomes. We investigated the association of diabetes, defined categorically, and the association of HbA1c as a continuous measure, with postoperative outcomes. RESEARCH DESIGN AND METHODS: In this prospective, observational study, we measured the HbA1c of surgical inpatients age ≥54 years at a tertiary hospital between May 2013 and January 2016. Patients were diagnosed with diabetes if they had preexisting diabetes or an HbA1c ≥6.5% (48 mmol/mol) or with prediabetes if they had an HbA1c between 5.7 and 6.4% (39 and 48 mmol/mol). Patients with an HbA1c <5.7% (39 mmol/mol) were categorized as having normoglycemia. Baseline demographic and clinical data were obtained from hospital records, and patients were followed for 6 months. Random-effects logistic and negative binomial regression models were used for analysis, treating surgical units as random effects. We undertook classification and regression tree (CART) analysis to design a 6-month mortality risk model. RESULTS: Of 7,565 inpatients, 30% had diabetes, and 37% had prediabetes. After adjusting for age, Charlson comorbidity index (excluding diabetes and age), estimated glomerular filtration rate, and length of surgery, diabetes was associated with increased 6-month mortality (adjusted odds ratio [aOR] 1.29 [95% CI 1.05-1.58]; P = 0.014), major complications (1.32 [1.14-1.52]; P < 0.001), intensive care unit (ICU) admission (1.50 [1.28-1.75]; P < 0.001), mechanical ventilation (1.67 [1.32-2.10]; P < 0.001), and hospital length of stay (LOS) (adjusted incidence rate ratio [aIRR] 1.08 [95% CI 1.04-1.12]; P < 0.001). Each percentage increase in HbA1c was associated with increased major complications (aOR 1.07 [1.01-1.14]; P = 0.030), ICU admission (aOR 1.14 [1.07-1.21]; P < 0.001), and hospital LOS (aIRR 1.05 [1.03-1.06]; P < 0.001). CART analysis confirmed a higher risk of 6-month mortality with diabetes in conjunction with other risk factors. CONCLUSIONS: Almost one-third of surgical inpatients age ≥54 years had diabetes. Diabetes and higher HbA1c were independently associated with a higher risk of adverse outcomes after surgery.
Authors: Floris van Raalten; Yasmine L Hiemstra; Noor Keulen; Yoni van Duivenvoorde; Katrin Stoecklein; Evert A Verhagen; Christa Boer Journal: J Clin Monit Comput Date: 2019-01-18 Impact factor: 2.502
Authors: Felix Aberer; Verena Theiler-Schwetz; Haris Ziko; Bettina Hausegger; Iris Wiederstein-Grasser; Daniel A Hochfellner; Philipp Eller; Georg Tomberger; Martin Ellmerer; Julia K Mader; Vladimir Bubalo Journal: Sci Rep Date: 2020-04-20 Impact factor: 4.379
Authors: Lisa D Yee; Joanne E Mortimer; Rama Natarajan; Eric C Dietze; Victoria L Seewaldt Journal: Front Endocrinol (Lausanne) Date: 2020-02-20 Impact factor: 5.555